<?xml version="1.0" encoding="UTF-8"?>
<p id="par0100">SSHT has been shown to inhibit coxsackievirus B1 infection by inducing the expression of type I interferons
 <xref rid="bib0110" ref-type="bibr">22</xref>, 
 <xref rid="bib0115" ref-type="bibr">23</xref> and has been reported to inhibit antigen production through chemical promoters against Epstein-Barr virus.
 <xref rid="bib0120" ref-type="bibr">
  <sup>24</sup>
 </xref> It has also been reported that SSHT could prevent hepatitis C virus (HCV) disease progression by promoting interleukin-10 and -12 production.
 <xref rid="bib0125" ref-type="bibr">
  <sup>25</sup>
 </xref>
</p>
